Capital World Investors Deciphera Pharmaceuticals, Inc. Transaction History

Capital World Investors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$7.7 - $37.13 $2.08 Million - $10 Million	-270,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$33.63 - $69.4 $7.32 Million - $15.1 Million	-217,696 Reduced 44.64%	270,000 $11.1 Million
Q4 2019 Feb 18, 2020	BUY	$31.7 - $69.93 $6.9 Million - $15.2 Million	217,696 Added 80.63%	487,696 $30.4 Million
Q3 2019 Nov 14, 2019	BUY	$19.95 - $38.85 $5.39 Million - $10.5 Million	270,000 New	270,000 $9.16 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

Stay updated on Capital World Investors with notifications on news.